专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US09126253B2 Mold for press forming 有权
标题翻译：模压成型
公开(公告)号：US09126253B2
公开(公告)日：2015-09-08
申请号：US13879632
申请日：2011-01-28
申请人： Naoki Ichijo , Yoshiya Sato , Isao Nojiri
发明人： Naoki Ichijo , Yoshiya Sato , Isao Nojiri
IPC分类号： B21D22/02 , B21D37/10 , B21D37/20 , B30B15/02
CPC分类号： B21D22/02 , B21D37/10 , B21D37/20 , B30B15/02
摘要： A lightweight mold for press forming is presented. Molds are characterized in that design forming portions thereof, these design forming portions making contact with a workpiece at the time of press forming and thereby forming a target design on the workpiece, are constructed of rod shaped members (design forming rods). By having the design forming portions be constructed of rod shaped members, the weight of the mold is reduced. It is preferred that the molds are further provided with supporting rods which support the design forming rods, these rod members constituting a framework structure.
摘要翻译：提出了一种用于冲压成型的轻质模具。模具的特征在于，其设计形成部分，这些在压制成型时与工件接触并由此在工件上形成目标设计的设计形成部分由杆形构件（设计成型杆）构成。通过使设计形成部分由棒状构件构成，模具的重量减小。优选地，模具还设置有支撑杆，支撑杆支撑设计形成杆，这些杆构件构成框架结构。

2. 发明申请

US20110142955A1 AGENT FOR AMELIORATING STRESS-INDUCED IMMUNE FUNCTION MODULATION 审中-公开
标题翻译：用于调整应力诱导免疫功能调节剂
公开(公告)号：US20110142955A1
公开(公告)日：2011-06-16
申请号：US13054367
申请日：2009-07-15
申请人： Yoshiya Sato , Kaiissar Mannoor , Hisami Watanabe , Kikuji Yamaguchi , Mayu Tsukamoto
发明人： Yoshiya Sato , Kaiissar Mannoor , Hisami Watanabe , Kikuji Yamaguchi , Mayu Tsukamoto
IPC分类号： A61K35/64 , A61P37/02
CPC分类号： A61K35/644 , A23L2/52 , A23L21/20 , A23L33/10
摘要： The present invention relates to an agent for ameliorating stress-induced immune function modulation which comprises royal jelly. In addition, the present invention provides an anti-stress agent, pharmaceutical, food or beverage, or food additive that contains royal jelly as an active ingredient thereof and prevents or alleviates various somatic symptoms caused by stress.
摘要翻译：本发明涉及一种用于改善包含蜂王浆的应激诱导的免疫功能调节剂。此外，本发明提供了含有蜂王浆作为其活性成分的抗应激剂，药物，食品或饮料或食品添加剂，并且防止或减轻由应力引起的各种体细胞症状。

3. 发明申请

US20060246087A1 Hetero type pentamer recombinant vaccine 失效
标题翻译：异种五聚体重组疫苗
公开(公告)号：US20060246087A1
公开(公告)日：2006-11-02
申请号：US10565595
申请日：2004-07-23
申请人： Takeshi Arakawa , Masanao Kikukawa , Isao Shimabukuro , Masayuki Tadano , Yasunobu Matsumoto , Naotoshi Tsuji , Yoshiya Sato
发明人： Takeshi Arakawa , Masanao Kikukawa , Isao Shimabukuro , Masayuki Tadano , Yasunobu Matsumoto , Naotoshi Tsuji , Yoshiya Sato
IPC分类号： A61K39/12 , C07H21/04 , C12N15/86 , C07K14/18
CPC分类号： A61K39/12 , A61K39/385 , A61K2039/541 , A61K2039/6037 , A61K2039/627 , A61K2039/64 , A61K2039/645 , C07K14/005 , C07K14/245 , C07K14/28 , C07K2319/00 , C07K2319/55 , C07K2319/74 , C12N2770/24122 , C12N2770/24134 , Y02A50/39
摘要： A heteropentamer composed of a fusion monomer (32) comprising a fusion protein of an antigenic amino acid sequence and an amino acid sequence of a monomer of a mucous membrane-binding protein and a nonfusion monomer (20) of an amino acid sequence of a monomer of a mucous membrane-binding protein. A homopentamer composed of a fusion monomer including a fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a monomer of a mucous membrane-binding protein. These heteropentamer and the homopentamer can be used as a vaccine.
摘要翻译：由包含抗原性氨基酸序列的融合蛋白和粘膜结合蛋白的单体的氨基酸序列和单体的氨基酸序列的非融合单体（20）的融合单体（32）组成的异戊二敏单体的粘膜结合蛋白。由包含衍生自日本脑炎病毒的包膜蛋白的抗原的融合蛋白和粘膜结合蛋白的单体的氨基酸序列的融合单体组成的同销口。这些异戊酸和异戊酸可以用作疫苗。

4. 发明授权

US06411091B1 Coil for MRI apparatus 失效
标题翻译： MRI仪器线圈
公开(公告)号：US06411091B1
公开(公告)日：2002-06-25
申请号：US09976719
申请日：2001-10-13
申请人： Sunao Sugiura , Yoshiya Sato
发明人： Sunao Sugiura , Yoshiya Sato
IPC分类号： G01V300
CPC分类号： G01R33/34069
摘要： With the objective of reducing the coupling capacitance of a pattern crossing section in a simple structure thereby to produce a high-quality tomographic image based on a larger value of the coil, a magnetic resonance signal receiving coil includes a pair of first and second conductor patterns each having a partial conductor pattern set which branches into three partial conductor patterns at the pattern crossing section. Each confronting pair of the first and second partial conductor patterns cross each other by being insulated from each other at the pattern crossing section. The partial conductor patterns of the first and second conductor patterns have their one ends beyond the crossing section each connected together to other ends of the second and first conductor patterns by arcuate conductors. The conductor patterns have their open ends connected to the signal outlets by conductor bars.
摘要翻译：为了以简单的结构减小图案交叉部分的耦合电容，从而基于线圈的较大值产生高品质断层图像，磁共振信号接收线圈包括一对第一和第二导体图案每个具有在图案交叉部分分支成三个部分导体图案的部分导体图案组。第一和第二部分导体图案的每个相对的一对在图案交叉部分彼此绝缘彼此交叉。第一和第二导体图案的部分导体图案的一端超过交叉部分，每个通过弧形导体连接在第二和第一导体图案的另一端。导体图案的开口端通过导体条连接到信号出口。

5. 发明授权

US07544361B2 Hetero type pentamer recombinant vaccine 失效
标题翻译：异种五聚体重组疫苗
公开(公告)号：US07544361B2
公开(公告)日：2009-06-09
申请号：US10565595
申请日：2004-07-23
申请人： Takeshi Arakawa , Masanao Kikukawa , Isao Shimabukuro , Masayuki Tadano , Yasunobu Matsumoto , Naotoshi Tsuji , Yoshiya Sato
发明人： Takeshi Arakawa , Masanao Kikukawa , Isao Shimabukuro , Masayuki Tadano , Yasunobu Matsumoto , Naotoshi Tsuji , Yoshiya Sato
IPC分类号： A61K39/385 , A61K39/12 , A61K39/295 , A61K9/28 , C07K19/00 , C07K17/00 , C12N15/62 , C12N15/63 , C12N1/21
CPC分类号： A61K39/12 , A61K39/385 , A61K2039/541 , A61K2039/6037 , A61K2039/627 , A61K2039/64 , A61K2039/645 , C07K14/005 , C07K14/245 , C07K14/28 , C07K2319/00 , C07K2319/55 , C07K2319/74 , C12N2770/24122 , C12N2770/24134 , Y02A50/39
摘要： A heteropentamer composed of a fusion monomer (32) comprising a fusion protein of an antigenic amino acid sequence and an amino acid sequence of a monomer of a mucous membrane-binding protein and a nonfusion monomer (20) of an amino acid sequence of a monomer of a mucous membrane-binding protein. A homopentamer composed of a fusion monomer including a fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a monomer of a mucous membrane-binding protein. These heteropentamer and the homopentamer can be used as a vaccine.
摘要翻译：由包含抗原性氨基酸序列的融合蛋白和粘膜结合蛋白的单体的氨基酸序列和单体的氨基酸序列的非融合单体（20）的融合单体（32）组成的异戊二敏单体的粘膜结合蛋白。由包含源自日本脑炎病毒的包膜蛋白的抗原的融合蛋白和粘膜结合蛋白的单体的氨基酸序列的融合单体构成的同销口。这些异戊酸和异戊酸可以用作疫苗。

6. 发明授权

US08658226B2 Agent having anti-Helicobacter pylori activity 有权
标题翻译：具有抗幽门螺杆菌活性的药剂
公开(公告)号：US08658226B2
公开(公告)日：2014-02-25
申请号：US13126770
申请日：2009-10-30
申请人： Yoshiya Sato , Hiromu Toma , Hironori Iwasaki , Kikuji Yamaguchi
发明人： Yoshiya Sato , Hiromu Toma , Hironori Iwasaki , Kikuji Yamaguchi
IPC分类号： A61K36/53 , A61K36/00
CPC分类号： A61K36/53 , A23L33/105 , A23V2002/00 , A61K36/535 , A23V2250/21
摘要： The present invention provides an agent having anti-Helicobacter pylori activity that is effective for the treatment, prevention or improvement of diseases associated with Helicobacter pylori and contains as an active ingredient thereof an extract of a plant belonging to the Labiatae family. The agent having anti-Helicobacter pylori activity of the present invention has superior heat stability and allows the obtaining of elimination effects in a short period of time.
摘要翻译：本发明提供了具有抗幽门螺杆菌活性的药剂，其有效用于治疗，预防或改善与幽门螺杆菌相关的疾病，并且作为活性成分含有属于Labiatae家族的植物的提取物。具有本发明的抗幽门螺杆菌活性的药剂具有优异的热稳定性，并且能够在短时间内获得消除效果。

7. 发明申请

US20100209527A1 COMPOSITION FOR PREVENTION OR TREATMENT OF DISEASE ASSOCIATED WITH PRODUCTION OF AUTOANTIBODY 审中-公开
标题翻译：用于预防或治疗与生产自身免疫相关的疾病的组合物
公开(公告)号：US20100209527A1
公开(公告)日：2010-08-19
申请号：US12670244
申请日：2008-07-23
申请人： Yoshiya Sato , Kaiisar Mannoor , Isao Shimabukuro , Kikuji Yamaguchi
发明人： Yoshiya Sato , Kaiisar Mannoor , Isao Shimabukuro , Kikuji Yamaguchi
IPC分类号： A61K35/64 , A61P37/06
CPC分类号： A61K35/644 , A23L2/52 , A23L21/20 , A61K35/744 , A61K2300/00
摘要： The invention provides a composition for prevention or treatment of a disease associated with the production of an autoantibody.Specifically, it provides a composition for prevention or treatment of a disease associated with the production of an autoantibody, which comprises royal jelly as an active ingredient.
摘要翻译：本发明提供了用于预防或治疗与自身抗体产生相关的疾病的组合物。具体地说，本发明提供一种用于预防或治疗与生产自身抗体相关的疾病的组合物，其包含蜂王浆作为活性成分。

8. 发明申请

US20130291614A1 MOLD FOR PRESS FORMING 有权
标题翻译：模压成型
公开(公告)号：US20130291614A1
公开(公告)日：2013-11-07
申请号：US13879632
申请日：2011-01-28
申请人： Naoki Ichijo , Yoshiya Sato , Isao Nojiri
发明人： Naoki Ichijo , Yoshiya Sato , Isao Nojiri
IPC分类号： B21D22/02
CPC分类号： B21D22/02 , B21D37/10 , B21D37/20 , B30B15/02
摘要： A lightweight mold for press forming is presented. Molds are characterized in that design forming portions thereof, these design forming portions making contact with a workpiece at the time of press forming and thereby forming a target design on the workpiece, are constructed of rod shaped members (design forming rods). By having the design forming portions be constructed of rod shaped members, the weight of the mold is reduced. It is preferred that the molds are further provided with supporting rods which support the design forming rods, these rod members constituting a framework structure.
摘要翻译：提出了一种用于冲压成型的轻质模具。模具的特征在于，其设计形成部分，这些在压制成型时与工件接触并由此在工件上形成目标设计的设计形成部分由杆形构件（设计成型杆）构成。通过使设计形成部分由棒状构件构成，模具的重量减小。优选地，模具还设置有支撑杆，支撑杆支撑设计形成杆，这些杆构件构成框架结构。

9. 发明申请

US20110206791A1 AGENT HAVING ANTI-HELICOBACTER PYLORI ACTIVITY 有权
标题翻译：具有抗真菌素活性的试剂
公开(公告)号：US20110206791A1
公开(公告)日：2011-08-25
申请号：US13126770
申请日：2009-10-30
申请人： Yoshiya Sato , Hiromu Toma , Hironori Iwasaki , Kikuji Yamaguchi
发明人： Yoshiya Sato , Hiromu Toma , Hironori Iwasaki , Kikuji Yamaguchi
IPC分类号： A01N65/22 , A61K36/53 , A01P1/00 , A61P31/04
CPC分类号： A61K36/53 , A23L33/105 , A23V2002/00 , A61K36/535 , A23V2250/21
摘要： The present invention provides an agent having anti-Helicobacter pylori activity that is effective for the treatment, prevention or improvement of diseases associated with Helicobacter pylori and contains as an active ingredient thereof an extract of a plant belonging to the Labiatae family. The agent having anti-Helicobacter pylori activity of the present invention has superior heat stability and allows the obtaining of elimination effects in a short period of time.
摘要翻译：本发明提供了具有抗幽门螺杆菌活性的药剂，其有效用于治疗，预防或改善与幽门螺杆菌相关的疾病，并且作为活性成分含有属于Labiatae家族的植物的提取物。具有本发明的抗幽门螺杆菌活性的药剂具有优异的热稳定性，并且能够在短时间内获得消除效果。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式